3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Precancerous Conditions
1
Neoplasms by Site
1
Neoplasms
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Female Urogenital Diseases and Pregnancy Complications
1
Interventions
Mitomycin
3
Abiraterone Acetate
3
motexafin gadolinium
2
abiraterone
2
Suspensions
2
Sunitinib
2
Powders
2
Paclitaxel
2
Gemcitabine
2
Drug Therapy
2
Docetaxel
2
vinflunine
1
valrubicin
1
temsirolimus
1
sipuleucel-T
1
pembrolizumab
1
palbociclib
1
onapristone
1
olaparib
1
niraparib
1
luprolide acetate gel depot
1
gallium 68 PSMA-11
1
enfortumab vedotin
1
darolutamide
1
atezolizumab
1
apalutamide
1
abemaciclib
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Tinzaparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Urogenital Neoplasms
×
Pregnancy Tests
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled